126 related articles for article (PubMed ID: 24378322)
1. MTP gene polymorphisms and postprandial lipemia in familial combined hyperlipidemia: effects of treatment with atorvastatin.
Klop B; Verseyden C; Ribalta J; Salazar J; Masana L; Cabezas MC
Clin Investig Arterioscler; 2014; 26(2):49-57. PubMed ID: 24378322
[TBL] [Abstract][Full Text] [Related]
2. Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemia.
Castro Cabezas M; Verseyden C; Meijssen S; Jansen H; Erkelens DW
J Clin Endocrinol Metab; 2004 Dec; 89(12):5972-80. PubMed ID: 15579746
[TBL] [Abstract][Full Text] [Related]
3. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.
Castro Cabezas M; Erkelens DW; Kock LA; De Bruin TW
Eur J Clin Invest; 1994 Oct; 24(10):669-78. PubMed ID: 7851467
[TBL] [Abstract][Full Text] [Related]
4. Effects of atorvastatin on fasting plasma and marginated apolipoproteins B48 and B100 in large, triglyceride-rich lipoproteins in familial combined hyperlipidemia.
Verseyden C; Meijssen S; Cabezas MC
J Clin Endocrinol Metab; 2004 Oct; 89(10):5021-9. PubMed ID: 15472200
[TBL] [Abstract][Full Text] [Related]
5. Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia.
Boquist S; Karpe F; Danell-Toverud K; Hamsten A
Atherosclerosis; 2002 May; 162(1):163-70. PubMed ID: 11947910
[TBL] [Abstract][Full Text] [Related]
6. Influence of microsomal triglyceride transfer protein promoter polymorphism -493 GT on fasting plasma triglyceride values and interaction with treatment response to atorvastatin in subjects with heterozygous familial hypercholesterolaemia.
García-García AB; González C; Real JT; Martín de Llano JJ; González-Albert V; Civera M; Chaves FJ; Ascaso JF; Carmena R
Pharmacogenet Genomics; 2005 Apr; 15(4):211-8. PubMed ID: 15864113
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride-lowering effect of pitavastatin in a guinea pig model of postprandial lipemia.
Aoki T; Yamazaki H; Tamaki T; Sato F; Kitahara M; Saito Y
Arzneimittelforschung; 2003; 53(3):154-8. PubMed ID: 12705169
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin reduces postprandial accumulation and cholesteryl ester transfer protein-mediated remodeling of triglyceride-rich lipoprotein subspecies in type IIb hyperlipidemia.
Guerin M; Egger P; Le Goff W; Soudant C; Dupuis R; Chapman MJ
J Clin Endocrinol Metab; 2002 Nov; 87(11):4991-5000. PubMed ID: 12414863
[TBL] [Abstract][Full Text] [Related]
9. Effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipedemia.
Lee SH; Park S; Kang SM; Jang Y; Chung N; Choi D
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):65-71. PubMed ID: 21386036
[TBL] [Abstract][Full Text] [Related]
10. Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease.
Dane-Stewart CA; Watts GF; Pal S; Chan D; Thompson P; Hung J; Mamo JC
Metabolism; 2003 Oct; 52(10):1279-86. PubMed ID: 14564679
[TBL] [Abstract][Full Text] [Related]
11. Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia.
Verseyden C; Meijssen S; van Dijk H; Jansen H; Castro Cabezas M
J Lipid Res; 2003 Nov; 44(11):2100-8. PubMed ID: 12923226
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia.
Nordøy A; Svensson B; Hansen JB
J Thromb Haemost; 2003 Apr; 1(4):690-7. PubMed ID: 12871402
[TBL] [Abstract][Full Text] [Related]
13. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
14. Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment.
Llaverias G; Pou J; Ros E; Zambón D; Cofán M; Sánchez A; Vázquez-Carrera M; Sánchez RM; Laguna JC; Alegret M
Pharmacogenomics; 2008 Aug; 9(8):1035-54. PubMed ID: 18681780
[TBL] [Abstract][Full Text] [Related]
15. Postprandial plasma ApoB-48 levels are influenced by a polymorphism in the promoter of the microsomal triglyceride transfer protein gene.
Lundahl B; Hamsten A; Karpe F
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):289-93. PubMed ID: 11834530
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
[TBL] [Abstract][Full Text] [Related]
17. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
[TBL] [Abstract][Full Text] [Related]
18. Allelic polymorphism -491A/T in apo E gene modulates the lipid-lowering response in combined hyperlipidemia treatment.
García-Otín AL; Civeira F; Aristegui R; Díaz C; Recalde D; Sol JM; Masramon X; Hernández G; Pocoví M;
Eur J Clin Invest; 2002 Jun; 32(6):421-8. PubMed ID: 12059987
[TBL] [Abstract][Full Text] [Related]
19. Microsomal triglyceride transfer protein -493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles.
Lundahl B; Skoglund-Andersson C; Caslake M; Bedford D; Stewart P; Hamsten A; Packard CJ; Karpe F
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E739-45. PubMed ID: 16291571
[TBL] [Abstract][Full Text] [Related]
20. Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia.
Nordøy A; Hansen JB; Brox J; Svensson B
Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):7-16. PubMed ID: 11383326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
